Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effects of Spironolactone Combination Therapy on Proteinuria, Kidney Function, and Blood Pressure

This study has been completed.
Information provided by (Responsible Party):
Alireza Esteghamati, Tehran University of Medical Sciences Identifier:
First received: August 15, 2012
Last updated: August 27, 2012
Last verified: August 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2012
  Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)